ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The lower relapse rate and better survival advantages of haploidentical allograft compared with HLA-matched sibling donor allografts for intermediate- and adverse-risk AML patients with pretransplantation minimal residual disease

Wang, Ming; Wang, Bixia; Xu, Lan-Ping; Wang, Yu; Zhang, Xiao-Hui; Cheng, Yi-fei; Sun, Yu-Qian; Zhang, Yuan-Yuan; Liu, Yan-Rong; Chang, Ying-Jun; Liu, Kai-Yan; Huang, Xiao-Jun*北京大学; 南方医科大学
Bone Marrow Transplantation2023-2DOI: 10.1038/s41409-022-01872-7
3被引9阅读
引用收藏
分享

学科与关键词

关键词
VERSUS-HOST-DISEASEDIAGNOSIS
相关
加载中…
  • The Efficacy and Safety of Modified Melphalan and Busulfan-Based Conditioning Regimen for Allogeneic-HSCT in Refractory/Relapsed or Persistent MRD Positive AML Patients
    Chen, Shulian; Zhang, Xiaoyu; Zhai, Weihua; He, Yi; Feng, Sizhou; Han, Mingzhe; Niu, Ting; Xu, Yajing; Gao, Guangxun; Fan, Shengjin; Zhou, Zeping; Zhou, Fang; Rui, Xi; Liu, Li; Yang, Wei; Liu, Qifa; Zhang, Xi; Jiang, Erlie64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
  • Adding 5-day decitabine to the conditioning regimen for haploidentical bone marrow transplantation in aplastic anaemia patients results in satisfactory clinical outcomes
    Tang, LinQing; Wu, YiTing; Lei, RuiQi; Liu, Jie; Guo, Dan; Zhao, YanQiu; Li, HuiBo*; Fan, ShengJin*Bone Marrow Transplantation, 2022, 57(9): 1461-1463.
  • The Modified Melphalan-Cladribine- Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo- HSCT in Refractory/Relapsed AML
    Zhang, Xiaoyu; Chen, Shulian; Zhai, Weihua; He, Yi; Feng, Sizhou; Han, Mingzhe; Niu, Ting; Xu, Yajing; Gao, Guangxun; Fan, Shengjin; Zhou, Zepin; Zhou, Fang; Xi, Rui; Liu, Li; Yang, Wei; Zhang, Xi; Liu, Qifa; Jiang, Erlie65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
查看全部 →

发表信息

论文状态
公开发表
期刊
Bone Marrow Transplantation
发表日期
2023-02
卷期
第 58 卷, 第 2 期
页码
215-218
DOI
10.1038/s41409-022-01872-7
语言
ENGLISH
成果收录
SCIE
资助标注
National Key Research and Development Program [2017YFA0104500, 2019YFC0840606]; National Natural Science Foundation of China [81870139, 81530046, 81930004]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81621001]; Peking University Clinical Scientist Program [BMU2019LCKXJ003]; Science and Technology Project of Guangdong Province of China [2016B030230003]

作者

  • W

    Wang, Ming (第一作者)

    peking univ · southern med univ

  • W

    Wang, Bixia

    peking univ · southern med univ

查看全部 12 位作者收起作者
  • X

    Xu, Lan-Ping

    peking univ

  • W

    Wang, Yu

    peking univ

  • Z

    Zhang, Xiao-Hui

    peking univ

  • C

    Cheng, Yi-fei

    peking univ

  • S

    Sun, Yu-Qian

    peking univ

  • Z

    Zhang, Yuan-Yuan

    peking univ

  • L

    Liu, Yan-Rong

    peking univ

  • C

    Chang, Ying-Jun

    peking univ

  • L

    Liu, Kai-Yan

    peking univ

  • H

    Huang, Xiao-Jun (通讯)

    peking univ · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417